| abstract |
The invention relates to structural carotenoid analogs for the inhibition and amelioration of the disease. The invention also relates to compositions comprising structural carotenoid analogs and a use thereof. The structural carotenoid analogs are used for inhibiting and/or ameliorating the occurrence of diseases associated with reactive oxygen species, reactive nitrogen species, radicals and/or non-radicals, for example, the inhibition and/or amelioration of ischemia-reperfusion injury, the inhibition and/or amelioration of liver disease, and the inhibition and/or amelioration of cancer. |